Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Autosomal recessive primary microcephaly (MCPH) is a congenital neurodevelopmental disorder defined by a reduced head circumference at birth and non-progressive intellectual disability. MCPH results from impaired neuronal precursor proliferation leading to diminished cortical neuron numbers in an architecturally normal brain (PMID:25951892).
CENPJ (centromere protein J), also known as CPAP, was mapped to the MCPH6 locus on chromosome 13q12.12-q12.13 in a single consanguineous Pashtoon family. Sequence analysis revealed a homozygous four-base deletion in exon 11, predicted to truncate the protein and disrupt centrosomal function (PMID:16900296).
Inheritance is autosomal recessive with no additional segregating relatives beyond the index family. The only molecular lesion reported is a protein-truncating variant c.3275dup (p.Tyr1092Ter) observed in homozygosity in affected siblings, consistent with loss-of-function as the pathogenic mechanism (PMID:16900296).
Functional assays define CPAP as essential for centriole biogenesis. Truncation of its microtubule-destabilizing domain within amino acids 311–422 abrogates both tubulin-binding and microtubule-destabilizing activities in vitro, implicating disrupted spindle dynamics in MCPH pathogenesis (PMID:18586240).
CPAP is also required for ciliogenesis in neuronal cells: CPAP depletion inhibits cilia formation, and this phenotype is rescued by wild-type but not by an MDD mutant (KR377EE), demonstrating that intrinsic tubulin-dimer binding is critical for centrosome-mediated cilia assembly (PMID:23213448).
Disease-associated missense variants further corroborate pathogenicity. The E1235V mutation impairs centriole elongation, spindle orientation and leads to p53-dependent neuronal apoptosis in hiPSC-derived brain organoids, faithfully recapitulating the MCPH phenotype (PMID:35309908; PMID:37823337).
Modifier analyses reveal that heterozygous variants in CEP63, WDR62, RAD50 and PCNT can exacerbate phenotypic severity in CENPJ-mutant backgrounds, indicating allelic and locus interplay in neural precursor proliferation and informing genetic counseling strategies (PMID:34068194).
In summary, homozygous truncating variants in CENPJ cause autosomal recessive primary microcephaly through CPAP loss-of-function, impairing centriole dynamics and ciliogenesis. Although genetic evidence is limited to a single family, multiple concordant functional studies provide moderate mechanistic support. Key take-home: CENPJ testing has direct clinical utility for diagnosis and genetic counseling in MCPH.
Gene–Disease AssociationLimitedSingle homozygous truncating CENPJ variant in one family [PMID:16900296] Genetic EvidenceLimitedOne proband family with homozygous loss-of-function variant; no additional segregation Functional EvidenceModerateMultiple in vitro and organoid model studies demonstrate CPAP dysfunction in centriole biogenesis and ciliogenesis |